202 related articles for article (PubMed ID: 10234734)
1. Tetrahydro-2H-1,3,5-thiadiazine-5-(4-pyridylcarboxamide)-2-thione derivatives as prodrugs for isoniazid; synthesis, investigations and in vitro antituberculous activity.
Aboul-Fadl T; Hassanin K
Pharmazie; 1999 Apr; 54(4):244-7. PubMed ID: 10234734
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
Hearn MJ; Cynamon MH
Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
5. New carriers for representative peptides and peptide drugs.
Aboul-Fadl T; El Shorbagi AN
Arch Pharm (Weinheim); 1997 Nov; 330(11):327-32. PubMed ID: 9431024
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antifungal activities of some new tetrahydro-2H-1,3,5-thiadiazine-2-thiones.
Ertan M; Ayyildiz HG; Yulug N
Arzneimittelforschung; 1991 Nov; 41(11):1182-5. PubMed ID: 1810266
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new 3-substituted-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-l,3,5-thiadiazine-2-thione derivatives with potential antimicrobial activity.
Hussein MA; Hashem M
Arch Pharm (Weinheim); 2008 Jun; 341(6):370-6. PubMed ID: 18493973
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
[TBL] [Abstract][Full Text] [Related]
10. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
12. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and antifungal activities of some 3-(2-phenylethyl)-5-substituted- tetrahydro-2H-1,3,5-thiadiazine-2-thiones.
Ertan M; Bilgin AA; Palaska E; Yulug N
Arzneimittelforschung; 1992 Feb; 42(2):160-3. PubMed ID: 1610428
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-substituted-5-(4-carb oxycyclohexylmethyl) - tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as antifibrinolytic and antimicrobial agents.
Ozçelik AB; Ersan S; Ural AU; Ozkan S; Ertan M
Arzneimittelforschung; 2007; 57(8):554-9. PubMed ID: 17915644
[TBL] [Abstract][Full Text] [Related]
15. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
Kumar A; Patel G; Menon SK
Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation.
Ramani AV; Monika A; Indira VL; Karyavardhi G; Venkatesh J; Jeankumar VU; Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2012 Apr; 22(8):2764-7. PubMed ID: 22440626
[TBL] [Abstract][Full Text] [Related]
18. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.
Sriram D; Yogeeswari P; Gopal G
Eur J Med Chem; 2005 Dec; 40(12):1373-6. PubMed ID: 16129516
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]